The pericyte: A forgotten cell type with important implications for alzheimer's disease?

Brain Pathology

Volumn 24, Issue 4, 2014, Pages 371-386

  Winkler, Ethan A ^a,b   Sagare, Abhay P ^a   Zlokovic, Berislav V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; amyloid beta; blood brain barrier; hypoperfusion; neurodegeneration; pericytes

Indexed keywords

ALZHEIMER DISEASE; ANGIOGENESIS; BLOOD BRAIN BARRIER; BLOOD FLOW; BRAIN PERFUSION; BRAIN PERICYTE; CELL PHAGOCYTOSIS; CELL TYPE; CONFERENCE PAPER; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENOTYPE; HUMAN; MOLECULAR INTERACTION; NERVE CELL DEGENERATION; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; PATHOLOGY; PATHOPHYSIOLOGY; PERICYTE; PHYSIOLOGY; VASCULARIZATION;

ALZHEIMER DISEASE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; HUMANS; PERICYTES;

EID: 84902652960     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12152     Document Type: Conference Paper

References (202)

1. Abramsson A, Kurup S, Busse M, Yamada S, Lindblom P, Schallmeiner E, et al. (2007) Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development. Genes Dev 21: 316-331.
2. Ai J, Sun LH, Che H, Zhang R, Zhang TZ, Wu WC, et al. (2013) MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats. J Neurosci 33: 3989-4001.
3. Allinson KR, Lee HS, Fruttiger M, McCarty JH, Arthur HM, (2012) Endothelial expression of TGFbeta type II receptor is required to maintain vascular integrity during postnatal development of the central nervous system. PLoS ONE 7: e39336.
4. Armulik A, Genove G, Betsholtz C, (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21: 193-215.
5. Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, et al. (2010) Pericytes regulate the blood-brain barrier. Nature 468: 557-561.
6. Attwell D, (2013) Cerebral pericytes are critical regulators of cerebral blood flow in health and disease [Abstract]. Aarhus CTTH workshop, Aarhus, Denmark.
7. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA, (2010) Glial and neuronal control of brain blood flow. Nature 468: 232-243.
8. Austin BP, Nair VA, Meier TB, Xu G, Rowley HA, Carlsson CM, et al. (2011) Effects of hypoperfusion in Alzheimer's disease. J Alzheimers Dis 26 (Suppl. 3): 123-133.
9. Bading JR, Yamada S, Mackic JB, Kirkman L, Miller C, Calero M, et al. (2002) Brain clearance of Alzheimer's amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy. J Drug Target 10: 359-368.
10. Ballatore C, Lee VM, Trojanowski JQ, (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8: 663-672.
11. Baloyannis SJ, Baloyannis IS, (2012) The vascular factor in Alzheimer's disease: a study in Golgi technique and electron microscopy. J Neurol Sci 322: 117-121.
12. Bell RD, Deane R, Chow N, Long X, Sagare A, Singh I, et al. (2009) SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat Cell Biol 11: 143-153.
13. Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, Deane R, Zlokovic BV, (2007) Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27: 909-918.
14. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV, (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68: 409-427.
15. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485: 512-516.
16. Bell RD, Zlokovic BV, (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118: 103-113.
17. Bink DI, Ritz K, Aronica E, van der Weerd L, Daemen MJ, (2013) Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition. J Cereb Blood Flow Metab 33: 1666-1684.
18. Bobbie MW, Roy S, Trudeau K, Munger SJ, Simon AM, (2010) Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice. Invest Ophthalmol Vis Sci 51: 3758-3763.
19. Bowman GL, Kaye JA, Quinn JF, (2012) Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease. Curr Gerontol Geriatr Res 2012: 184042.
20. Braun A, Xu H, Hu F, Kocherlakota P, Siegel D, Chander P, et al. (2007) Paucity of pericytes in germinal matrix vasculature of premature infants. J Neurosci 27: 12012-12024.
21. Brown WR, Thore CR, (2011) Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 37: 56-74.
22. Burke MC, Nelson L, Slade JY, Oakley AE, Khundakar AA, Kalaria RN, (2014) Morphometry of the hippocampal microvasculature in post-stroke and age-related dementias. Neuropathol Appl Neurobiol 40: 284-295.
23. Candelario-Jalil E, Yang Y, Rosenberg GA, (2009) Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158: 983-994.
24. Castejon OJ, Castellano A, Arismendi GJ, Medina Z, (2005) The inflammatory reaction in human traumatic oedematous cerebral cortex. J Submicrosc Cytol Pathol 37: 43-52.
25. Castellano JM, Deane R, Gottesdiener AJ, Verghese PB, Stewart FR, West T, et al. (2012) Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Abeta clearance in a mouse model of beta-amyloidosis. Proc Natl Acad Sci U S A 109: 15502-15507.
26. Chen B, Cheng Q, Yang K, Lyden PD, (2010) Thrombin mediates severe neurovascular injury during ischemia. Stroke 41: 2348-2352.
27. Chen ZL, Strickland S, (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91: 917-925.
28. Chow N, Bell RD, Deane R, Streb JW, Chen J, Brooks A, et al. (2007) Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc Natl Acad Sci U S A 104: 823-828.
29. Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, et al. (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115: 3285-3290.
30. Conejero-Goldberg C, Gomar JJ, Bobes-Bascaran T, Hyde TM, Kleinman JE, Herman MM, et al. (2014) APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms. Mol Psychiatry [Epub ahead of print; doi: 10.1038/mp.2013.194 ].
31. Cordonnier C, van der Flier WM, (2011) Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain 134 (Pt 2): 335-344.
32. Cortes-Canteli M, Paul J, Norris EH, Bronstein R, Ahn HJ, Zamolodchikov D, et al. (2010) Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Neuron 66: 695-709.
33. Cortes-Canteli M, Zamolodchikov D, Ahn HJ, Strickland S, Norris EH, (2012) Fibrinogen and altered hemostasis in Alzheimer's disease. J Alzheimers Dis 32: 599-608.
34. Cullen KM, Kocsi Z, Stone J, (2005) Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex. J Cereb Blood Flow Metab 25: 1656-1667.
35. Daneman R, Zhou L, Kebede AA, Barres BA, (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468: 562-566.
36. Darland DC, Massingham LJ, Smith SR, Piek E, Saint-Geniez M, D'Amore PA, (2003) Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol 264: 275-288.
37. Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, et al. (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9: 907-913.
38. Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, et al. (2008) apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118: 4002-4013.
39. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, et al. (2004) LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43: 333-344.
40. Deschaintre Y, Richard F, Leys D, Pasquier F, (2009) Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology 73: 674-680.
41. Diaz-Flores L, Gutierrez R, Madrid JF, Varela H, Valladares F, Acosta E, et al. (2009) Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 24: 909-969.
42. Dohgu S, Takata F, Yamauchi A, Nakagawa S, Egawa T, Naito M, et al. (2005) Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production. Brain Res 1038: 208-215.
43. Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, Miller MC, et al. (2006) RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol 112: 405-415.
44. Dore-Duffy P, (2008) Pericytes: pluripotent cells of the blood brain barrier. Curr Pharm Des 14: 1581-1593.
45. Dore-Duffy P, Owen C, Balabanov R, Murphy S, Beaumont T, Rafols JA, (2000) Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res 60: 55-69.
46. Dore-Duffy P, Wang S, Mehedi A, Katyshev V, Cleary K, Tapper A, et al. (2011) Pericyte-mediated vasoconstriction underlies TBI-induced hypoperfusion. Neurol Res 33: 176-186.
47. Eisele YS, Obermuller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, et al. (2010) Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330: 980-982.
48. Enge M, Bjarnegard M, Gerhardt H, Gustafsson E, Kalen M, Asker N, et al. (2002) Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J 21: 4307-4316.
49. Etchevers HC, Vincent C, Le Douarin NM, Couly GF, (2001) The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development 128: 1059-1068.
50. Farkas E, Luiten PG, (2001) Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64: 575-611.
51. Farrall AJ, Wardlaw JM, (2009) Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol Aging 30: 337-352.
52. Fernandez-Klett F, Offenhauser N, Dirnagl U, Priller J, Lindauer U, (2010) Pericytes in capillaries are contractile in vivo, but arterioles mediate functional hyperemia in the mouse brain. Proc Natl Acad Sci U S A 107: 22290-22295.
53. Fiala M, Liu QN, Sayre J, Pop V, Brahmandam V, Graves MC, Vinters HV, (2002) Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur J Clin Invest 32: 360-371.
54. Gaengel K, Genove G, Armulik A, Betsholtz C, (2009) Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29: 630-638.
55. Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, et al. (2011) APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 16: 903-907.
56. Gerhardt H, Betsholtz C, (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314: 15-23.
57. Goos JD, Kester MI, Barkhof F, Klein M, Blankenstein MA, Scheltens P, van der Flier WM, (2009) Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke 40: 3455-3460.
58. Grammas P, (2011) Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation 8: 26.
59. Grammas P, Moore P, Weigel PH, (1999) Microvessels from Alzheimer's disease brains kill neurons in vitro. Am J Pathol 154: 337-342.
60. Gu X, Liu XY, Fagan A, Gonzalez-Toledo ME, Zhao LR, (2012) Ultrastructural changes in cerebral capillary pericytes in aged Notch3 mutant transgenic mice. Ultrastruct Pathol 36: 48-55.
61. Halliday MR, Pomara N, Sagare AP, Mack WJ, Frangione B, Zlokovic BV, (2013) Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown. JAMA Neurol 70: 1198-1200.
62. Hamilton NB, Attwell D, Hall CN, (2010) Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. Front Neuroenergetics 2. pii: 5. doi: 10.3389/fnene.2010.00005.
63. Hanyu H, Tanaka Y, Shimizu S, Takasaki M, Abe K, (2003) Cerebral microbleeds in Alzheimer's disease. J Neurol 250: 1496-1497.
64. Harb R, Whiteus C, Freitas C, Grutzendler J, (2013) In vivo imaging of cerebral microvascular plasticity from birth to death. J Cereb Blood Flow Metab 33: 146-156.
65. Hardy J, Selkoe DJ, (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
66. Harris JJ, Jolivet R, Attwell D, (2012) Synaptic energy use and supply. Neuron 75: 762-777.
67. Hellstrom M, Gerhardt H, Kalen M, Li X, Eriksson U, Wolburg H, Betsholtz C, (2001) Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153: 543-553.
68. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C, (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126: 3047-3055.
69. Hirase H, Creso J, Singleton M, Bartho P, Buzsaki G, (2004) Two-photon imaging of brain pericytes in vivo using dextran-conjugated dyes. Glia 46: 95-100.
70. Horwood N, Davies DC, (1994) Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease. Virchows Arch 425: 69-72.
71. Hossmann KA, (1994) Viability thresholds and the penumbra of focal ischemia. Ann Neurol 36: 557-565.
72. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.
73. Hua Y, Keep RF, Hoff JT, Xi G, (2007) Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke 38 (2 Suppl.): 759-762.
74. Hultman K, Strickland S, Norris EH, (2013) The APOE varepsilon4/ varepsilon4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients. J Cereb Blood Flow Metab 33: 1251-1258.
75. Iadecola C, (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5: 347-360.
76. Iadecola C, (2013) The pathobiology of vascular dementia. Neuron 80: 844-866.
77. Ittner LM, Gotz J, (2011) Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 12: 65-72.
78. Jaeger LB, Dohgu S, Hwang MC, Farr SA, Murphy MP, Fleegal-DeMotta MA, et al. (2009) Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. J Alzheimers Dis 17: 553-570.
79. Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, Quaggin SE, (2011) Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 121: 2278-2289.
80. Jellinger KA, (2010) Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases. Neurodegener Dis 7: 112-115.
81. Kalaria RN, Akinyemi R, Ihara M, (2012) Does vascular pathology contribute to Alzheimer changes? J Neurol Sci 322: 141-147.
82. Kalaria RN, Harik SI, (1989) Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J Neurochem 53: 1083-1088.
83. Kamouchi M, Kitazono T, Ago T, Wakisaka M, Ooboshi H, Ibayashi S, Iida M, (2004) Calcium influx pathways in rat CNS pericytes. Brain Res Mol Brain Res 126: 114-120.
84. Kanekiyo T, Liu CC, Shinohara M, Li J, Bu G, (2012) LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-beta. J Neurosci 32: 16458-16465.
85. Kim SM, Kim MJ, Rhee HY, Ryu CW, Kim EJ, Petersen ET, Jahng GH, (2013) Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele. Neuroradiology 55: 25-34.
86. Knopman DS, Roberts R, (2010) Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis 20: 699-709.
87. Koike MA, Green KN, Blurton-Jones M, Laferla FM, (2010) Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol 177: 300-310.
88. Kokovay E, Li L, Cunningham LA, (2006) Angiogenic recruitment of pericytes from bone marrow after stroke. J Cereb Blood Flow Metab 26: 545-555.
89. Korn J, Christ B, Kurz H, (2002) Neuroectodermal origin of brain pericytes and vascular smooth muscle cells. J Comp Neurol 442: 78-88.
90. Kurz H, (2009) Cell lineages and early patterns of embryonic CNS vascularization. Cell Adh Migr 3: 205-210.
91. Lacalle-Aurioles M, Mateos-Perez JM, Guzman-De-Villoria JA, Olazaran J, Cruz-Orduna I, Aleman-Gomez Y, et al. (2014) Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease. J Cereb Blood Flow Metab 34: 654-659.
92. Lamagna C, Bergers G, (2006) The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol 80: 677-681.
93. Larson EB, Yaffe K, Langa KM, (2013) New insights into the dementia epidemic. N Engl J Med 369: 2275-2277.
94. Lebrin F, Srun S, Raymond K, Martin S, van den Brink S, Freitas C, et al. (2010) Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 16: 420-428.
95. Li F, Lan Y, Wang Y, Wang J, Yang G, Meng F, et al. (2011) Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev Cell 20: 291-302.
96. Li J, Huang X, Xu X, Mayo J, Bringas P Jr, Jiang R, et al. (2011) SMAD4-mediated WNT signaling controls the fate of cranial neural crest cells during tooth morphogenesis. Development 138: 1977-1989.
97. Lindahl P, Johansson BR, Leveen P, Betsholtz C, (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242-245.
98. Marchesi VT, (2011) Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J 25: 5-13.
99. Marcus DL, Freedman ML, (1997) Decreased brain glucose metabolism in microvessels from patients with Alzheimer's disease. Ann N Y Acad Sci 826: 248-253.
100. Marcus DL, de Leon MJ, Goldman J, Logan J, Christman DR, Wolf AP, et al. (1989) Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol 26: 91-94.
101. Matz PG, Lewen A, Chan PH, (2001) Neuronal, but not microglial, accumulation of extravasated serum proteins after intracerebral hemolysate exposure is accompanied by cytochrome c release and DNA fragmentation. J Cereb Blood Flow Metab 21: 921-928.
102. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. (2010) Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 330: 1774.
103. Mazlo M, Gasz B, Szigeti A, Zsombok A, Gallyas F, (2004) Debris of "dark" (compacted) neurones are removed from an otherwise undamaged environment mainly by astrocytes via blood vessels. J Neurocytol 33: 557-567.
104. Mazza M, Marano G, Traversi G, Bria P, Mazza S, (2011) Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. J Alzheimers Dis 23: 375-389.
105. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, et al. (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313: 1781-1784.
106. Mhatre M, Nguyen A, Kashani S, Pham T, Adesina A, Grammas P, (2004) Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiol Aging 25: 783-793.
107. Mooradian AD, Chung HC, Shah GN, (1997) GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol Aging 18: 469-474.
108. Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, et al. (2006) Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 47: 1778-1786.
109. Moskowitz MA, Lo EH, Iadecola C, (2010) The science of stroke: mechanisms in search of treatments. Neuron 67: 181-198.
110. Nazer B, Hong S, Selkoe DJ, (2008) LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model. Neurobiol Dis 30: 94-102.
111. Niwa K, Carlson GA, Iadecola C, (2000) Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J Cereb Blood Flow Metab 20: 1659-1668.
112. Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C, (2002) Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis 9: 61-68.
113. Niwa K, Porter VA, Kazama K, Cornfield D, Carlson GA, Iadecola C, (2001) A beta-peptides enhance vasoconstriction in cerebral circulation. Am J Physiol Heart Circ Physiol 281: H2417-H2424.
114. Niwa K, Younkin L, Ebeling C, Turner SK, Westaway D, Younkin S, et al. (2000) Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci U S A 97: 9735-9740.
115. Oishi K, Kamiyashiki T, Ito Y, (2007) Isometric contraction of microvascular pericytes from mouse brain parenchyma. Microvasc Res 73: 20-28.
116. Okamoto Y, Yamamoto T, Kalaria RN, Senzaki H, Maki T, Hase Y, et al. (2012) Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol 123: 381-394.
117. Ozerdem U, Stallcup WB, (2003) Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis 6: 241-249.
118. Ozerdem U, Stallcup WB, (2004) Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis 7: 269-276.
119. Paris D, Humphrey J, Quadros A, Patel N, Crescentini R, Crawford F, Mullan M, (2003) Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation. Neurol Res 25: 642-651.
120. Paris D, Patel N, DelleDonne A, Quadros A, Smeed R, Mullan M, (2004) Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 366: 80-85.
121. Park L, Wang G, Zhou P, Zhou J, Pitstick R, Previti ML, et al. (2011) Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta. Proc Natl Acad Sci U S A 108: 5063-5068.
122. Park L, Zhou J, Zhou P, Pistick R, El Jamal S, Younkin L, et al. (2013) Innate immunity receptor CD36 promotes cerebral amyloid angiopathy. Proc Natl Acad Sci U S A 110: 3089-3094.
123. Park L, Zhou P, Koizumi K, El Jamal S, Previti ML, Van Nostrand WE, et al. (2013) Brain and circulating levels of Abeta1-40 differentially contribute to vasomotor dysfunction in the mouse brain. Stroke 44: 198-204.
124. Paul J, Strickland S, Melchor JP, (2007) Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J Exp Med 204: 1999-2008.
125. Peinado MA, Quesada A, Pedrosa JA, Torres MI, Martinez M, Esteban FJ, et al. (1998) Quantitative and ultrastructural changes in glia and pericytes in the parietal cortex of the aging rat. Microsc Res Tech 43: 34-42.
126. Peppiatt CM, Howarth C, Mobbs P, Attwell D, (2006) Bidirectional control of CNS capillary diameter by pericytes. Nature 443: 700-704.
127. Perrin RJ, Fagan AM, Holtzman DM, (2009) Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461: 916-922.
128. Peters A, Sethares C, (2012) Age-related changes in the morphology of cerebral capillaries do not correlate with cognitive decline. J Comp Neurol 520: 1339-1347.
129. Petzold GC, Murthy VN, (2011) Role of astrocytes in neurovascular coupling. Neuron 71: 782-797.
130. Pieper C, Marek JJ, Unterberg M, Schwerdtle T, Galla HJ, (2014) Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro. Brain Res 1550: 1-8.
131. Piquer-Gil M, Garcia-Verdugo JM, Zipancic I, Sanchez MJ, Alvarez-Dolado M, (2009) Cell fusion contributes to pericyte formation after stroke. J Cereb Blood Flow Metab 29: 480-485.
132. Protas HD, Chen K, Langbaum JB, Fleisher AS, Alexander GE, Lee W, et al. (2013) Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol 70: 320-325.
133. Querfurth HW, LaFerla FM, (2010) Alzheimer's disease. N Engl J Med 362: 329-344.
134. Regan RF, Guo Y, (1998) Toxic effect of hemoglobin on spinal cord neurons in culture. J Neurotrauma 15: 645-653.
135. Richard E, Gouw AA, Scheltens P, van Gool WA, (2010) Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) study. Stroke 41: 554-556.
136. Rouget C, (1873) Memoire sur le developpement, la structures et les proprietes des capillaries sanguins et lymphatiques. Arch Physiol Norm Pathol 5: 603-633.
137. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM, (2005) Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57: 789-794.
138. Ryu JK, McLarnon JG, (2009) A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J Cell Mol Med 13 (9A): 2911-2925.
139. Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A, Zlokovic BV, (2013) Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun 4: 2932.
140. Sagare AP, Bell RD, Zlokovic BV, (2012) Neurovascular dysfunction and faulty amyloid beta-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med 2: a011452.
141. Sagare AP, Bell RD, Zlokovic BV, (2013) Neurovascular defects and faulty amyloid-beta vascular clearance in Alzheimer's disease. J Alzheimers Dis 33 (Suppl. 1): S87-S100.
142. Saint-Pol J, Vandenhaute E, Boucau MC, Candela P, Dehouck L, Cecchelli R, et al. (2012) Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-beta peptide accumulation. J Alzheimers Dis 30: 489-503.
143. Salloway S, Gur T, Berzin T, Tavares R, Zipser B, Correia S, et al. (2002) Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease. J Neurol Sci 203-204: 183-187.
144. Saunders WB, Bohnsack BL, Faske JB, Anthis NJ, Bayless KJ, Hirschi KK, Davis GE, (2006) Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J Cell Biol 175: 179-191.
145. Schneider JA, Bennett DA, (2010) Where vascular meets neurodegenerative disease. Stroke 41 (10 Suppl.): S144-S146.
146. Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic BV, (2013) Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol 23: 303-310.
147. Sheline YI, Morris JC, Snyder AZ, Price JL, Yan Z, D'Angelo G, et al. (2010) APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42. J Neurosci 30: 17035-17040.
148. Shepro D, Morel NM, (1993) Pericyte physiology. FASEB J 7: 1031-1038.
149. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. (2000) Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106: 1489-1499.
150. Sieczkiewicz GJ, Herman IM, (2003) TGF-beta 1 signaling controls retinal pericyte contractile protein expression. Microvasc Res 66: 190-196.
151. Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, Avison MJ, (1999) Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology 53: 1391-1396.
152. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR, (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277: 813-817.
153. Song W, Barth JL, Yu Y, Lu K, Dashti A, Huang Y, et al. (2005) Effects of oxidized and glycated LDL on gene expression in human retinal capillary pericytes. Invest Ophthalmol Vis Sci 46: 2974-2982.
154. Spires TL, Hyman BT, (2005) Transgenic models of Alzheimer's disease: learning from animals. NeuroRx 2: 423-437.
155. Stenzel D, Nye E, Nisancioglu M, Adams RH, Yamaguchi Y, Gerhardt H, (2009) Peripheral mural cell recruitment requires cell-autonomous heparan sulfate. Blood 114: 915-924.
156. Stratman AN, Malotte KM, Mahan RD, Davis MJ, Davis GE, (2009) Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 114: 5091-5101.
157. Stratman AN, Schwindt AE, Malotte KM, Davis GE, (2010) Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood 116: 4720-4730.
158. Tagami M, Nara Y, Kubota A, Fujino H, Yamori Y, (1990) Ultrastructural changes in cerebral pericytes and astrocytes of stroke-prone spontaneously hypertensive rats. Stroke 21: 1064-1071.
159. Tallquist MD, French WJ, Soriano P, (2003) Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development. PLoS Biol 1: E52.
160. Tanzi RE, (2012) The genetics of Alzheimer disease. Cold Spring Harb Perspect Med 2: a006296.
161. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M, (1996) beta-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380: 168-171.
162. Thomas WE, (1999) Brain macrophages: on the role of pericytes and perivascular cells. Brain Res Brain Res Rev 31: 42-57.
163. Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, et al. (2013) Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain 136 (Pt 9): 2697-2706.
164. Tong XK, Lecrux C, Rosa-Neto P, Hamel E, (2012) Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits. J Neurosci 32: 4705-4715.
165. de la Torre JC, (2012) Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J Alzheimers Dis 32: 553-567.
166. Tsai PS, Kaufhold JP, Blinder P, Friedman B, Drew PJ, Karten HJ, et al. (2009) Correlations of neuronal and microvascular densities in murine cortex revealed by direct counting and colocalization of nuclei and vessels. J Neurosci 29: 14553-14570.
167. Uh J, Lewis-Amezcua K, Martin-Cook K, Cheng Y, Weiner M, Diaz-Arrastia R, et al. (2010) Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity. Neurobiol Aging 31: 2038-2046.
168. Ujiie M, Dickstein DL, Carlow DA, Jefferies WA, (2003) Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10: 463-470.
169. Van Geest RJ, Klaassen I, Vogels IM, Van Noorden CJ, Schlingemann RO, (2010) Differential TGF-{beta} signaling in retinal vascular cells: a role in diabetic retinopathy? Invest Ophthalmol Vis Sci 51: 1857-1865.
170. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM, (2003) Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348: 1215-1222.
171. Vinters HV, Secor DL, Read SL, Frazee JG, Tomiyasu U, Stanley TM, et al. (1994) Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. Ultrastruct Pathol 18: 333-348.
172. Virgintino D, Girolamo F, Errede M, Capobianco C, Robertson D, Stallcup WB, et al. (2007) An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis. Angiogenesis 10: 35-45.
173. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539.
174. Wang Y, Pan L, Moens CB, Appel B, (2014) Notch3 establishes brain vascular integrity by regulating pericyte number. Development 141: 307-317.
175. Wilhelmus MM, Otte-Holler I, van Triel JJ, Veerhuis R, Maat-Schieman ML, Bu G, et al. (2007) Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells. Am J Pathol 171: 1989-1999.
176. Winkler EA, Bell RD, Zlokovic BV, (2010) Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling. Mol Neurodegener 5: 32.
177. Winkler EA, Bell RD, Zlokovic BV, (2011) Central nervous system pericytes in health and disease. Nat Neurosci 14: 1398-1405.
178. Winkler EA, Sengillo JD, Bell RD, Wang J, Zlokovic BV, (2012) Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability. J Cereb Blood Flow Metab 32: 1841-1852.
179. Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SH, Zlokovic BV, (2013) Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol 125: 111-120.
180. Wisniewski HM, Wegiel J, Wang KC, Lach B, (1992) Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 84: 117-127.
181. Wu EX, Tang H, Asai T, Yan SD, (2004) Regional cerebral blood volume reduction in transgenic mutant APP (V717F, K670N/M671L) mice. Neurosci Lett 365: 223-227.
182. Wu J, Hua Y, Keep RF, Schallert T, Hoff JT, Xi G, (2002) Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res 953: 45-52.
183. Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R, et al. (2005) Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat Med 11: 959-965.
184. Yamada K, Hashimoto T, Yabuki C, Nagae Y, Tachikawa M, Strickland DK, et al. (2008) The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells. J Biol Chem 283: 34554-34562.
185. Yamada M, Ihara M, Okamoto Y, Maki T, Washida K, Kitamura A, et al. (2011) The influence of chronic cerebral hypoperfusion on cognitive function and amyloid beta metabolism in APP overexpressing mice. PLoS ONE 6: e16567.
186. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, et al. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
187. Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T, (2009) Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 15: 1031-1037.
188. Yin X, Wright J, Wall T, Grammas P, (2010) Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease. Am J Pathol 176: 1600-1606.
189. Zhiyou C, Yong Y, Shanquan S, Jun Z, Liangguo H, Ling Y, Jieying L, (2009) Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease. Neurochem Res 34: 1226-1235.
190. Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O'Banion MK, et al. (2008) ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 11: 420-422.
191. Zhong Z, Ilieva H, Hallagan L, Bell R, Singh I, Paquette N, et al. (2009) Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J Clin Invest 119: 3437-3449.
192. Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, et al. (2007) Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging 28: 977-986.
193. Zlokovic BV, (1995) Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier. Pharm Res 12: 1395-1406.
194. Zlokovic BV, (2005) Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28: 202-208.
195. Zlokovic BV, (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178-201.
196. Zlokovic BV, (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12: 723-738.
197. Zlokovic BV, (2013) Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. JAMA Neurol 70: 440-444.
198. Zlokovic BV, Begley DJ, Chain-Eliash DG, (1985) Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine). Brain Res 336: 125-132.
199. Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA, (2010) Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid beta-peptide elimination from the brain. J Neurochem 115: 1077-1089.
200. Zlokovic BV, Hyman S, McComb JG, Lipovac MN, Tang G, Davson H, (1990) Kinetics of arginine-vasopressin uptake at the blood-brain barrier. Biochim Biophys Acta 1025: 191-198.
201. Zlokovic BV, Mackic JB, Djuricic B, Davson H, (1989) Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain. J Neurochem 53: 1333-1340.
202. Zlokovic BV, Segal MB, Begley DJ, Davson H, Rakic L, (1985) Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone. Brain Res 358: 191-199.